Global Induced Pluripotent Stem Cells (iPSCs) Market 2022-2028

The global induced pluripotent stem cells market size is projected to grow by USD 2 billion from 2022 to 2028, registering a CAGR of 8.6 percent, according to a new report by Gen Consulting Company.

The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global induced pluripotent stem cells market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the induced pluripotent stem cells industry.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the function, reprogramming method, method, application, and region. The global market for induced pluripotent stem cells can be segmented By function cell analysis, cell culture, cell differentiation, cellular and molecular bioengineering, cellular reprogramming. In 2021, the cell differentiation segment made up the largest share of revenue generated by the induced pluripotent stem cells market. Induced pluripotent stem cells market is further segmented By reprogramming method integrated, non-integrated. The non-integrated segment was the largest contributor to the global induced pluripotent stem cells market in 2021. Based on method, the induced pluripotent stem cells market is segmented into: DNA-based, protein-based, RNA-based, small molecule-based. The DNA-based segment is estimated to account for the largest share of the global induced pluripotent stem cells market. On the basis of application, the induced pluripotent stem cells market also can be divided into: academic research, drug development, regenerative medicine. The drug development segment held the largest share of the global induced pluripotent stem cells market in 2021 and is anticipated to hold its share during the forecast period. Induced pluripotent stem cells market by region is categorized into: Asia Pacific, Europe, USA, Rest of the World (RoW).

By function:
- cell analysis
- cell culture
- cell differentiation
- cellular and molecular bioengineering
- cellular reprogramming

By reprogramming method:
- integrated
- non-integrated

By method:
- DNA-based
- protein-based
- RNA-based
- small molecule-based

By applicationt:
- academic research
- drug development
- regenerative medicine

By region:
- Asia Pacific
- Europe
- USA
- Rest of the World (RoW)

The report explores the recent developments and profiles of key vendors in the Global Induced Pluripotent Stem Cells Market, including Bio-Techne Corporation, BlueRock Therapeutics LP, Bristol Myers Squibb (BMS), Cell Signaling Technology, Inc., Corning Incorporated, FUJIFILM Cellular Dynamics, Inc., InvivoGen Limited, Lonza Group AG, Merck KGaA, Promega Corporation, Qiagen N.V., STEMCELL Technologies Inc., Thermo Fisher Scientific Inc., among others.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Historical & Forecast Period
This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.

Scope of the Report
- To analyze and forecast the market size of the global induced pluripotent stem cells market.
- To classify and forecast the global induced pluripotent stem cells market based on function, reprogramming method, method, application, region.
- To identify drivers and challenges for the global induced pluripotent stem cells market.
- To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global induced pluripotent stem cells market.
- To identify and analyze the profile of leading players operating in the global induced pluripotent stem cells market.

Why Choose This Report
- Gain a reliable outlook of the global induced pluripotent stem cells market forecasts from 2022 to 2028 across scenarios.
- Identify growth segments for investment.
- Stay ahead of competitors through company profiles and market data.
- The market estimate for ease of analysis across scenarios in Excel format.
- Strategy consulting and research support for three months.
- Print authentication provided for the single-user license.
TABLE OF CONTENTS
FIGURES AND TABLES
PART 1. INTRODUCTION
Report description
Objectives of the study
Market segment
Years considered for the report
Currency
Key target audience
PART 2. METHODOLOGY
PART 3. EXECUTIVE SUMMARY
PART 4. MARKET OVERVIEW
Introduction
Drivers
Restraints
Impact of COVID-19 pandemic
PART 5. MARKET BREAKDOWN BY FUNCTION
Cell analysis
Cell culture
Cell differentiation
Cellular and molecular bioengineering
Cellular reprogramming
PART 6. MARKET BREAKDOWN BY REPROGRAMMING METHOD
Integrated
Non-integrated
PART 7. MARKET BREAKDOWN BY METHOD
DNA-based
Protein-based
RNA-based
Small molecule-based
PART 8. MARKET BREAKDOWN BY APPLICATION
Academic research
Drug development
Regenerative medicine
PART 9. MARKET BREAKDOWN BY REGION
Asia Pacific
Europe
USA
Rest of the World (RoW)
PART 10. KEY COMPANIES
Bio-Techne Corporation
BlueRock Therapeutics LP
Bristol Myers Squibb (BMS)
Cell Signaling Technology, Inc.
Corning Incorporated
FUJIFILM Cellular Dynamics, Inc.
InvivoGen Limited
Lonza Group AG
Merck KGaA
Promega Corporation
Qiagen N.V.
STEMCELL Technologies Inc.
Thermo Fisher Scientific Inc.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER

Global Biobanking Market 2022-2028

Biobanking refers to the process by which samples of bodily fluid or tissue are collected for research use to improve our understanding of health and diseases. The global biobanking market

USD 2600 View Report

Global 3D Bioprinting Market 2022-2028

In 2021, the global 3d bioprinting market stood at USD 817 million. Recording a CAGR of 17.3% from 2022 to 2028, the worth is projected to reach ~USD 2,496 million

USD 2600 View Report

Global Induced Pluripotent Stem Cells Market Research Report 2015-2027 of Major Types, Applications and Competitive Vendors in Top Regions and Countries

The Global market for Induced Pluripotent Stem Cells is estimated to grow at a CAGR of roughly X.X% in the next 8 years, and will reach USD X.X million in

USD 2960 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available